| Literature DB >> 34556713 |
Christoph Arneitz1, Jana Windhaber1, Christina Flucher1, Paolo Gasparella1, Eva Amerstorfer1, Andrea Huber-Zeyringer1, Christoph Castellani1, Georg Singer2, Holger Till1.
Abstract
The aim of this study was to assess whether adolescents following anorectal malformation repair have a decreased cardiorespiratory performance capacity and impaired motor skills. All eligible children treated for ARMs between 2000 and 2014 were invited to participate in a prospective study consisting of a clinical examination, evaluation of Bowel function and Quality of Life, spirometry, spiroergometry and assessment of the motor activity. The results were compared to a healthy age- and sex-matched control group. There was no statistically significant difference in height, weight, BMI, muscle mass or body fat percentage between the study and the control group. Nine out of 18 patients (50%) had an excellent functional outcome with a normal Bowel Function Score. Spirometry revealed no significant differences between ARM patients and controls, four patients showed a ventilation disorder. Spiroergometry revealed a significantly lower relative performance capacity and the overall rating of the motor activity test showed significantly decreased grades in ARM patients. ARM patients were affected by an impaired cardiopulmonary function and decreased motor abilities. Long-term examinations consisting of routine locomotor function evaluation and spiroergometry are advisable to detect impaired cardiopulmonary function and to prevent a progression of associated complications and related impaired quality of life.Entities:
Mesh:
Year: 2021 PMID: 34556713 PMCID: PMC8460638 DOI: 10.1038/s41598-021-98368-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
ARM patients, age at time of follow-up, type of malformation, surgery, BFS according to Rintala[23], QoL according to Bai et al.[4] and functional outcome.
| ID | Age | Gender | Type | Additional anomaly | Surgery | Rintala | Bai |
|---|---|---|---|---|---|---|---|
| Pat.1 | 9 | f | Perineal fistula | – | PSARPa | 19 | 10 |
| Pat.2 | 9 | f | Perineal fistula | – | PSARPa | 17 | 12 |
| Pat.3 | 9 | f | Perineal fistula | – | PSARPa | 15 | 11 |
| Pat.4 | 11 | f | Perineal fistula | – | PSARPa | 20 | 12 |
| Pat.5 | 11 | f | Rectovestibular fistula | Anophthalmus and duodenal atresia | PSARPa | 20 | 11 |
| Pat.6 | 13 | f | Perineal fistula | – | PSARPa | 17 | 13 |
| Pat.7 | 14 | f | Rectovestibular fistula | – | PSARPa | 16 | 13 |
| Pat.8 | 15 | f | Perineal fistula | – | PSARPa | 18 | 13 |
| Pat.9 | 15 | f | Perineal fistula | – | PSARPa | 20 | 13 |
| Pat.10 | 15 | f | Rectovestibular fistula | Currarino triad | PSARPb | 13 | 12 |
| Pat.11 | 16 | f | Rectovestibular fistula | – | PSARPa | 20 | 13 |
| Pat.12 | 16 | f | Perineal fistula | – | PSARPa | 9 | 10 |
| Pat.13 | 17 | f | Cloaca | EA, pancreas anulare, volvulus | Abd.-perineal pull-through | Colostomy | Colostomy |
| Pat.14 | 10 | m | Imperforate anus | – | PSARPa | 20 | 12 |
| Pat.15 | 13 | m | Perineal fistula | – | PSARPb | 18 | 13 |
| Pat.16 | 16 | m | Perineal fistula | – | PSARPa | 19 | 13 |
| Pat.17 | 17 | m | Rectovesical fistula | Caudal regression | PSARPb | 15 | 9 |
| Pat.18 | 18 | m | Rectobulbar fistula | – | PSARPb | 11 | 9 |
aOne-staged procedure (PSARP).
bThree-staged procedure (colostomy, PSARP, colostomy closure).
Anthropometric data, results of spirometry and spiroergometry and Dordel-Koch-Test (DKT) of ARM patients and controls (n = 18 each).
| ARM patients | Controls | ||
|---|---|---|---|
| n = 18 | n = 18 | ||
| Age | 13.6 ± 3.0 | 13.3 ± 3.1 | 0.828 $ |
| Gender (male/female) | 13/5 | 13/5 | 1.000 |
| Height [m] | 1.6 ± 0.1 | 1.6 ± 0.2 | 0.419 $ |
| Body weight [kg] | 49.7 ± 13.4 | 47.3 ± 15.8 | 0.636 $ |
| BMI Z-score | − 1.6 ± 5.9 | − 0.34 ± 1.1 | 0.913 |
| Body fat [%] | 15.1 ± 8.1 | 11.1 ± 7.3 | 0.134 # |
| Muscle mass [kg/height2] | 5.5 ± 1.7a | 6.0 ± 2.1 | 0.425 $ |
| VCmax [%] | 93.9 ± 13.3 | 102.0 ± 12.5 | 0.069 $ |
| Tiffeneau Index [%] | 86.6 ± 10.2 | 87.7 ± 5.2 | 0.695 $ |
| Relative performance [%] | 110.4 ± 19.2 | 127.8 ± 16.9 | |
| Peak VO2 [ml/kg/min] | 41 ± 8.2 | 45.6 ± 9.4 | 0.323 # |
| O2/HR [ml] | 10.7 ± 3.4 | 10.8 ± 4.1 | 0.927 $ |
| EQO2 | 20.7 ± 3.1 | 20.2 ± 2.5 | 0.557 $ |
| BR | 15.0 ± 14.9 | 19.7 ± 16.0 | 0.367 $ |
| ΔVO2/ΔWR | 11.4 ± 1.2 | 11.1 ± 1.3 | 0.444 $ |
| Lateral jumping | 4.1 ± 1.1 | 2.6 ± 1.1 | |
| Sit and reach | 3.6 ± 1 | 3.2 ± 0.9 | 0.279 # |
| Sit-ups | 3.7 ± 0.9 | 2.7 ± 0.8 | |
| Long stand jump | 4.1 ± 1.1 | 2.8 ± 0.9 | |
| One-legged stand | 2.2 ± 1.8 | 1 ± 0 | 0.091 # |
| Push-Ups | 2.7 ± 1.1 | 1.9 ± 0.8 | 0.059 # |
Bold values indicate statistically significant differences.
All data are displayed as mean ± standard deviation and statistical comparison was performed using either unpaired t-tests ($) or Mann–Whitney-U tests (#) depending on normal distribution and homogeneity of variances.
aMeasurement of muscle mass was technically not possible in one control patient.